Fredun Pharmaceuticals shares now tradable on NSE from Aug 17

Capital Market Events View source PDF Explain this filing

FREDUN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.6%Reaction day

₹1485.00

prior close

₹1450.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-3.0% vs market

Pharmaceuticals peers, median of 175sector+0.0%-2.6% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 2.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.7

10m

+2.2

15m

+3.2

30m

+3.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.6+0.4-3.0+0.0-2.6

Next day

-3.8-0.2-3.6-0.5-3.3

-0.7+0.3-1.0-0.1-0.5

-3.7+0.6-4.3-0.2-3.5

-4.2+0.8-5.1-0.4-3.8

-2.6+0.4-2.9-0.7-1.9

+0.2+0.7-0.5-0.6+0.8

15d

-8.4+2.0-10.4+1.7-10.1

-12.1+0.7-12.9+1.8-13.9

-3.4-3.4-0.0-4.2+0.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fredun Pharmaceuticals Limited's equity shares have been admitted to trading on the National Stock Exchange (NSE) with effect from August 17, 2026, under the symbol FREDUN with ISIN INE194R01017 and face value of Rs 10. The company was already listed on BSE under scrip code 539730. The NSE admission was granted via NSE circular dated August 14, 2026, under Regulation 3.1.1 of NSE trading rules.

Likely market impact

Dual listing on NSE may improve trading volumes, visibility, and liquidity for existing shareholders of Fredun Pharmaceuticals.